Schedule 13G ownership disclosure
Protara Therapeutics Inc
Common Stock, par value $0.001 per share · CUSIP: 74365U107
Event date: 2024-12-31
- Filing-level shares
- 1,825,000.00
- Percent of class
- 5.32%
- Opaleye Management, Inc.
Shares: 1,825,000.00 · Class: 5.32%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-25-006563
- Form type
- SCHEDULE 13G/A
- Filer
- Opaleye Management Inc.
- CIK
- CIK 1595855
- Filed
- Feb 14, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership